Motion analysis device developer dorsaVi (ASX: DVL) has dispatched its resistive random-access memory (RRAM)-powered sensor systems to Singapore. These systems are set for rigorous testing within real-world biomedical settings. dorsaVi specialises in wearable sensor technology and real-time biofeedback, empowering users to optimise movement and manage musculoskeletal conditions. The company aims to revolutionise human movement analysis, improving performance, rehabilitation, and workplace safety.
The testing will assess edge-device functionality under realistic conditions. The focus is on applications where traditional NAND flash memory struggles to meet the write demands of biosignal applications. This creates bottlenecks for wearable and mobile medical systems requiring real-time processing, increasing power consumption and reducing system lifespan.
dorsaVi will also test a hybrid RRAM-NAND memory configuration to demonstrate near-term performance gains. This approach builds a pathway toward fully RRAM-based systems as the technology matures. The company will use the test results to develop a scaling strategy for biomedical sensors. Applications include prosthetic control, implantables, e-skin, and closed-loop systems that can operate efficiently without performance compromises.
Gernot Abl, dorsaVi’s chair, stated that the company is eager to advance the commercial and technical opportunities presented by real-world movement analysis. He added that integrating RRAM into their sensor platform marks a pivotal step toward intelligent, low-power motion systems. He believes this technology will enhance existing solutions and pave the way for future applications in AI, robotics, and neuromorphic computing.
